Brief

On December 5, 2024, the Korea Food and Drug Administration (KFDA) held a policy briefing session to introduce the digital medical product regulatory system. The event aimed to inform industry stakeholders about the new regulations under the Digital Medical Product Act, which is set to take effect in January next year, focusing on clinical evaluation, permit, classification, and quality management for digital medical devices.

This content is restricted.

Highlights content goes here...

This content is restricted.

Korea Food and Drug Administration (KFDA)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies